Achromatopsia Market Size, Epidemiology, Treatment, Leading Companies, Drugs and Competitive Analysis by DelveInsight | EMAS Pharma, Janssen Research, Applied Genetic Technologies and More

Achromatopsia Market

Achromatopsia is a condition characterized by a partial or total absence of color vision. People with complete achromatopsia cannot perceive any colors; they see only black, white, and shades of gray. Incomplete achromatopsia is a milder form of the condition that allows some color discrimination.


DelveInsight’s “Achromatopsia Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Achromatopsia, historical and forecasted epidemiology as well as the Achromatopsia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.


Some key facts of Achromatopsia Market are:

Achromatopsia is a rare disorder with an estimated prevalence of fewer than 1:30,000
The congenital forms of the Achromatopsia are considered stationary and do not worsen with age.
Visual acuity and stability of the eye motions generally improve during the first six to seven years of life – but remain near 20/200. 


Scope of the Achromatopsia Report

The report covers the descriptive overview of Achromatopsia, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
Comprehensive insight has been provided into the Achromatopsia epidemiology and treatment in the 7MM
Additionally, an all-inclusive account of both the current and emerging therapies for Achromatopsia are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
A detailed review of Achromatopsia market; historical and forecasted is included in the report, covering drug outreach in the 7MM
The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Achromatopsia market


Request for Sample Report:


Achromatopsia also involves other problems with vision, including an increased sensitivity to light and glare (photophobia), involuntary back-and-forth eye movements (nystagmus), and significantly reduced sharpness of vision (low visual acuity). Affected individuals can also have farsightedness (hyperopia) or, less commonly, nearsightedness (myopia). These vision problems develop in the first few months of life.


Achromatopsia Companies covered:

EMAS Pharma  
Janssen Research & Development          
Applied Genetic Technologies Corp
MeiraGTx UK II Ltd
Syne Qua Non Limited
And Many Others


Achromatopsia Therapies:

And Many Others


Request for Sample Report:


Table of Contents:

1. Key Insights

2. Executive Summary of Achromatopsia

3. Competitive Intelligence Analysis for Achromatopsia

4. Achromatopsia: Market Overview at a Glance

4.1. Achromatopsia Total Market Share (%) Distribution in 2017

4.2. Achromatopsia Total Market Share (%) Distribution in 2030

5. Achromatopsia: Disease Background and Overview

6. Patient Journey

7. Achromatopsia Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

8.1. Achromatopsia Treatment and Management

8.2. Achromatopsia Treatment Algorithm

9. Unmet Needs

10. Key Endpoints of Achromatopsia Treatment

11. Marketed Products

List to be continued in report

12. Emerging Therapies

List to be continued in report

13. Achromatopsia: Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of Achromatopsia

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer


About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also provides Business Consulting Services with a credible market analysis that will help accelerate the business growth and overcome challenges with a practical approach. 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States